- Home
- IHT vs TENX Comparison
IHT vs TENX Comparison
Compare IHT & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHT
- TENX
- Stock Information
- Founded
- IHT 1971
- TENX 1967
- Country
- IHT United States
- TENX United States
- Employees
- IHT N/A
- TENX N/A
- Industry
- IHT Investment Bankers/Brokers/Service
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- IHT Finance
- TENX Health Care
- Exchange
- IHT Nasdaq
- TENX Nasdaq
- Market Cap
- IHT 21.5M
- TENX 21.6M
- IPO Year
- IHT N/A
- TENX N/A
- Fundamental
- Price
- IHT $2.50
- TENX $5.68
- Analyst Decision
- IHT
- TENX Strong Buy
- Analyst Count
- IHT 0
- TENX 3
- Target Price
- IHT N/A
- TENX $16.00
- AVG Volume (30 Days)
- IHT 2.1K
- TENX 12.6K
- Earning Date
- IHT 06-17-2025
- TENX 05-14-2025
- Dividend Yield
- IHT 0.79%
- TENX N/A
- EPS Growth
- IHT N/A
- TENX N/A
- EPS
- IHT N/A
- TENX N/A
- Revenue
- IHT $7,593,516.00
- TENX N/A
- Revenue This Year
- IHT N/A
- TENX N/A
- Revenue Next Year
- IHT N/A
- TENX N/A
- P/E Ratio
- IHT N/A
- TENX N/A
- Revenue Growth
- IHT 1.46
- TENX N/A
- 52 Week Low
- IHT $1.25
- TENX $2.77
- 52 Week High
- IHT $2.70
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- IHT 51.93
- TENX 49.30
- Support Level
- IHT $2.50
- TENX $5.49
- Resistance Level
- IHT $2.45
- TENX $5.87
- Average True Range (ATR)
- IHT 0.05
- TENX 0.27
- MACD
- IHT 0.00
- TENX 0.03
- Stochastic Oscillator
- IHT 61.36
- TENX 52.04
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.